Internal cam metering pump

Information

  • Patent Grant
  • 9416775
  • Patent Number
    9,416,775
  • Date Filed
    Wednesday, July 2, 2014
    9 years ago
  • Date Issued
    Tuesday, August 16, 2016
    7 years ago
Abstract
A micropump according to the invention uses an eccentric cam member rotating within a pump housing to sequentially open and close valves in the pump housing to withdraw fluid from a reservoir and provide metered amounts of the fluid to a cannula port for administration to a patient. The micropump may be used in a disposable pump for continuous infusion of medication such as insulin.
Description
BACKGROUND OF THE INVENTION

1. Field of the Invention


The present invention is directed to a micropump adapted for the continuous delivery of a liquid medication by infusion such as may be used in the delivery of insulin for the treatment of diabetes.


2. Description of the Related Art


Micropumps for the subcutaneous delivery of drugs are known, for example, from U.S. Pat. Nos. 7,726,955 and 8,282,366. This prior art describes, in various embodiments, a pump having a rotor mounted in a stator, or housing. Sealing rings situated at an angle on axial extensions on the rotor cooperate with channels formed between the rotor and the stator to move liquid in precise amounts through a rotor housing. However, these embodiments are relatively complex and not cost effective. The user keeps the pump when the infusion patch is changed, for several weeks. As the art continues to evolve toward fully disposable pumps, the need for compact and economical micropump designs remains acute.


Another infusion pump known in the prior art comprises a rigid reservoir with a lead screw engaged in the reservoir to dispense medication through the cannula as the lead screw advances. In this arrangement, the actuator for delivery of the medication is directly connected to the lead screw and must therefore be very precise. Moreover, the device requires the rigid reservoir to provide calibrated dosages. Thus it is impossible to use a flexible reservoir, and the number of possible layouts for the pump is limited.


SUMMARY OF THE INVENTION

In one aspect, the present invention is a micropump for delivery of medication by infusion, comprising: a pump housing; a piston positioned in the pump housing having a longitudinal piston axis; and a motor adapted to rotate the piston about the piston axis. The pump housing has an axial opening receiving the piston, a first aperture positioned radially with respect to the piston axis in fluid communication with a reservoir, and a second aperture radially positioned with respect to the piston axis in fluid communication with a cannula. The piston has an eccentric cam surface at one end thereof, said cam surface adapted to open and close the first aperture and the second aperture at respective rotational positions of the piston. The axial position of the piston inside the pump housing determines a pump volume space.


In embodiments, the pump housing is stationary and the piston comprises an axial position cam surface, between the motor and the eccentric cam surface, engaging a stationary member on the pump housing, adapted to translate the piston axially within the pump housing when the piston rotates.


In another aspect, the invention is a method for delivering medication by infusion with the above-described pump, including the steps of providing instructions to a microprocessor to deploy the cannula, and to cause the piston to rotate, drawing a volume of medication into the pump volume space from the reservoir and expelling the volume of medication through the cannula for infusion to a patient. In embodiments, the medication is insulin and the infusion dosage comprises an infusion over one to five days, and the method further comprises disposing of the pump after delivery of the infusion dosage.





BRIEF DESCRIPTION OF THE DRAWINGS


FIG. 1 is a schematic overview of the fluid metering and delivery systems according to the invention.



FIG. 2 is a view of the assembled fluid metering and delivery systems.



FIG. 3 is an exploded view of the fluid metering system.



FIG. 4A and FIG. 4B are top and end views of the pump piston element of the fluid metering system.



FIG. 5 and FIG. 6 are cross sectional views of the metering system.



FIG. 7 is a cross sectional view of the pump housing in the starting position of the pump cycle. FIG. 7A and FIG. 7B are corresponding partial cutaway views of the fluid delivery system in the stage depicted in FIG. 7, from different angles.



FIG. 8 is a cross sectional view of the pump housing in the early stages of a pump cycle, before the start of the intake stroke.



FIG. 9 is a cross sectional view of the pump housing during the intake stroke. FIG. 9A and FIG. 9B are corresponding partial cutaway views from different angles.



FIG. 10 is a cross sectional view of the pump housing after the intake stroke. FIG. 10A and FIG. 10B are corresponding partial cutaway views from different angles.



FIG. 11 is a cross sectional view of the pump housing prior to initiation of the discharge stroke. FIG. 11A and FIG. 11B are corresponding partial cutaway views from different angles.



FIG. 12 is a cross sectional view of the pump housing during the discharge stroke. FIG. 12A and FIG. 12B are corresponding partial cutaway views of the fluid delivery system during the discharge stroke from different angles.



FIG. 13 depicts the rotational position of the piston at the end of the pump cycle.





DETAILED DESCRIPTION OF THE INVENTION


FIG. 1 provides a schematic overview of a fluid delivery system 100, comprising a reservoir 120 in fluid communication with metering subsystem 200 for drawing a precise amount of fluid from the reservoir. A cannula mechanism 122 is provided for delivering medication from the metering subsystem 200 to the user 101. The fluid delivery system, including metering subsystem 200, is preferably lightweight and wearable and assembled in a compact form as shown in FIG. 2, so that the elements may be included in a single housing. The cannula mechanism 122 may be connected to the infusion site by an infusion set comprising tubing and a patch, or alternatively a cannula insertion mechanism may be incorporated into the housing along with the metering subsystem 200.


In embodiments, the pump is adapted to provide a continuous infusion dosage over 1 to 5 days. For example, in the case of insulin infusion, the pump may be worn and disposed of after 84 hours and the reservoir is sized to provide a dosage regimen in basal and bolus segments as a time varying series of fixed volume pulses. The infusion profile is split between the basal and bolus segments. For example, the basal segment may be a quasi-continuous flow of 5 μl pulses with a time lag that ranges from 0.17 to 1.2 hours/pulse, while the bolus segments comprise discrete volumes that generally occur around meal times, typically in a range of 10 to 500 μl, delivered at the maximum pump flow rate (minimum pump cycle time). In the case of insulin infusion, the reservoir 120 may be adapted to hold 1 ml to 5 ml of medication, preferably about 3 ml. However, this value is not critical. Although the invention is not limited to any specific reservoir embodiment, the reservoir 120 is preferably flexible and is not engaged with a plunger and lead screw, as is the case with many prior art insulin pumps. The flexible reservoir does not have an internal actuator mechanism for delivering fluid, which permits the overall pump to have a smaller footprint and more compact design. A suitable flexible reservoir may comprise a pouch made of medical grade flexible polyvinylchloride (PVC) or the like. Alternatively, a single rigid wall of medical grade plastic may be bonded to a flexible wall to form the reservoir. Reservoir 120 may be filled via a fill port 123 by syringe 121, for example, or a prefilled reservoir or cartridge may be used. Metering subsystem 200 may be configured in fluid communication with the fill port 123, so that metering subsystem 200 can be used to fill the reservoir 120 from an external source of medication via fill port 123.


Microcontroller 30 is provided on a printed circuit board (PCB) or the like and interfaces with sensors and circuitry 11, 12, 13, 14, 15, 17 and with actuators 16 and 18, to control the pump and cannula. As illustrated in FIG. 1, sensor 17 is an occlusion sensor or more generally an error condition sensor. Power is provided by one or more batteries 19 in the housing. Display and user operable controls (not shown) may be provided on the unit, operatively connected to the PCB, or on a remote programming unit, to set and initiate basal and bolus segments of the dosage, as is known in the prior art.


The embodiment of the metering system according to the invention depicted in the figures comprises a positive displacement pump with integrated flow control valves and a mechanical actuator and drive system. In the embodiment shown in FIG. 2, the actuator is a DC gear motor 24 powered by batteries 19, however, other motor systems may be adapted for use with the invention, including a solenoid, nitinol (nickel-titanium alloy) wire motor, voice coil actuator motor, piezoelectric motor, or wax motor. The elements are arranged on support 21 received in a housing (not shown) to be worn on the patient's body.


As shown in the exploded view of FIG. 3, the motor 24 is received in stationary motor casing 23. Connector 25 receives the motor shaft 22 of the motor 24 and transmits torque from the motor to pump piston 27. As used herein, the “axial” direction is along the axis of the motor shaft and the “radial” direction is the perpendicular direction. Unless the context clearly requires otherwise, the “clockwise” direction means clockwise looking down the axis of the motor shaft toward the motor. Slots 39 on piston 27 receive tabs 26 on connector 25 so that piston 27 rotates in unison with the motor shaft, but remains free to move axially. Alternatively, the piston may have rotational freedom but an axially fixed position, and the pump housing may be rotationally fixed but connected to the piston to allow for axial translation. In either case, the pump volume is determined by the axial position of a piston within the pump housing.


In the embodiment shown, pump piston 27 is received in an axial opening in a stationary pump housing 29 and encloses pump volume space 47 in the pump housing behind elastomeric seal 37. As shown in FIG. 4A, piston 27 is configured with an axial position cam surface 32. As described below, axial cam surface 32 engages a member on stationary pump housing 29 and causes piston 27 to translate axially within housing 29 when motor shaft 22 rotates. For example, in the embodiment shown, the member engaging the cam surface is a pin 31 inserted through the pump housing.


The metering subsystem 200 is adapted to pull a precise volume of fluid from flexible reservoir 120 into pump volume 47, and then expel the fluid through cannula 122 to an infusion site in small, discrete doses. A suitable pump volume space 47 may have a volume of 1 μl to 10 μl, preferably about 5 μl, so that two rotations of pump piston 27 deliver a unit (U) of insulin. Importantly, the position of pump piston 27 inside pump housing 29 determines the stroke, and the internal diameter of the pump housing determines the nominal size and accuracy of the dose. Therefore dosage accuracy is not determined by a specific rotational position of the motor shaft to deliver a corresponding amount of medication and the start/stop point for the rotational pump cycle need not be precise. The pump volume 47 may be altered by changing the diameter of piston 27 and/or pump housing 29. In embodiments, cannula deployment is triggered by rotation of motor 24, in a one-step deployment and infusion operation.


In order to pull fluid into pump volume 47 during the intake stroke, and expel fluid during the discharge stroke, piston 27 is provided with an eccentric cam surface 33, as shown in FIG. 4B, to actuate valves to sequentially open and close reservoir fluid port 42 and cannula fluid port 41 at each end of the pump stroke to ensure that fluid flow is unidirectional from the reservoir to the patient and that there is no possibility of flow from the patient to the reservoir. As shown in the cross-sectional view of FIG. 5, the pump housing is provided with first and second apertures 44, 43 positioned radially with respect to the pump piston axis. First aperture provides fluid communication between pump volume 47 and reservoir port 42, while second aperture 43 provides fluid communication between pump volume 47 and cannula port 41. In this embodiment, apertures 43, 44 are positioned on opposite sides of pump housing 29, 180 degrees apart with respect to piston 27. The angular allocation for each segment of the pump cycle may be adjusted as needed to optimize performance of the pump, by altering the size and slope of the eccentric cam surface 33, to increase or decrease the angular allocation for a particular portion of the pump cycle, or by changing the radial position of apertures 43, 44.


In the embodiment shown, the first and second apertures 44, 43 each receive a valve structure. Each valve structure includes respective O-ring seal 34, 34′ surrounding the aperture and a respective valve actuator 28, 28′ which compresses a respective O-ring seal 34, 34′ under force of respective spring 35, 35′ to close the respective aperture 43, 44 when cam surface 33 is not pressing against actuator 28, 28′. When cam surface 33 is rotated into position and depresses a valve actuator 28 or 28′, the fluid line to the cannula port 41 or reservoir port 42 is opened. The springs 35, 35′ are maintained in a biased state in the valve seat by respective valve caps 36, 36′ and must ensure sufficient spring force to prevent back flow at back pressures encountered during use of the device. Although O-rings are depicted in this embodiment, other sealing systems known in the art could be adapted for this purpose, such as an elastomeric ball in a V-shaped seat, an overmolded V-shaped poppet, or an overmolded membrane which can be biased to provide fluid entry through apertures 43, 44. In general, components of the metering subsystem are made of a rigid medical grade plastic, such as acrylonitrile butadiene styrene (ABS) for all of the pump components, while liquid silicone rubber (LSR) with shore A hardness between 20 and 50 is used for the seals. If desired, the LSR seals may be molded directly onto the hard plastic substrates, in which case the substrate parts should be made of a plastic material with a higher softening temperature such as polyetherimide (PEI) or polysulfone (PS).


In the embodiment depicted, pump housing 29 is stationary and piston 27 is translated inside the pump housing 29. For this purpose, piston 27 comprises an axial position cam surface in the form of a groove 32. As seen in FIG. 4A, groove 32 includes proximal ledge 32b located toward the motor 24 and a distal ledge 32a located toward eccentric cam surface 33 on the opposite end of piston 27 from motor 24. A stationary member, such as pin 31, is received through an opening in the pump housing and constrains the piston to move axially back and forth between the position of proximal ledge 32b and axial ledge 32a, guided along an axial translation portion of the groove 32, as motor shaft 22 rotates. One of ordinary skill in the art will appreciate that an axial cam surface on piston 27 engaging pump housing 29 may be embodied in various ways to provide for axial movement of piston 27. For example, a groove may be located on the pump housing instead of on the piston.


A complete pump cycle requires 360 degrees of rotation in one direction. Rotating motor shaft 22 in the reverse direction will cause fluid to flow in the opposite direction. In embodiments, the pump may be placed in fluid communication with fill port 123 to fill reservoir from an external source such as a vial by rotating the motor shaft in the reverse direction.


The pump cycle will be described with reference to a complete clockwise rotation (viewed looking down the piston toward the motor). The rotation of eccentric cam surface 33 about the piston axis, accompanied by the reciprocating action of piston 27 in this embodiment is understood by referring to the following sequential steps of the pump cycle described in FIG. 7 through FIG. 13: (1) reservoir valve open state, (2) pump intake stroke; (3) reservoir valve closed state; (4) cannula valve open state; (5) pump discharge stroke; and (6) cannula valve closed state.



FIG. 7 is a cross sectional view from the end of the pump housing, looking down the piston toward the motor, showing the metering system in its starting position. The pump piston 27 is fully extended. As shown in FIG. 7A and FIG. 7B, pin 31 rests on proximal ledge 32b in this position and the piston does not translate axially. Cam surface 33 is not engaged with either valve actuator 28 or 28′, and a slight clearance is provided between cam surface 33 and actuators 28 and 28′ on radially opposite sides of the pump housing. The cam surface 33 is said to be “in clearance” with the actuator tips in this state. In this state, the valves are closed by the force of springs acting on O-ring seals 34, 34′ through valve actuators 28 and 28′. In the initial state, valve actuators 28 and 28′ are spring loaded against valve caps 36 and 36′ so that they have a permanent bias sufficient to prevent leakage at the operating back pressures of the device. The valve actuator may rest on a shoulder in the pump housing around apertures 43, 44. In this way, compression of O-ring seals 34 or 34′ is determined by the geometry of the valve actuator cooperating with the surfaces of the pump housing around the apertures 43, 44, rather than solely on the spring force.



FIG. 8 depicts the reservoir valve open state (1) before the start of the intake stroke. Motor 24 is shown rotating in a clockwise direction so that cam surface 33 on piston 27 rotates to contact valve actuator 28 to bias spring 35 and open fluid communication with reservoir port 42. In this position, pin 31 has not yet entered the sloped axial translation portion of groove 32.


During the pump intake stroke (2) depicted in FIG. 9, FIG. 9A and FIG. 9B, actuator 28 is fully depressed. Fluid flows into the pump volume space 47 through reservoir port 42 and first aperture 44 while second aperture 43 remains closed. As shown in FIG. 9A and FIG. 9B, pin 31 engages the angled portion of axial cam surface 32 causing piston 27 to translate toward motor 24 in the direction indicated by arrow 99. Fluid is drawn into pump volume space 47 as indicated by arrow 98. The intake stroke is complete when pin 31 rests on distal ledge 32a, stopping axial movement of piston 27. Actuator 28 remains fully depressed and actuator 28′ remains in clearance with cam surface 33.



FIG. 10, FIG. 10A and FIG. 10B show reservoir port 42 closing. Rotation of piston 27 causes cam surface 33 to release actuator 28, recompressing seal 34 due to bias of spring 35 and stopping fluid flow through first aperture 44. During this portion of the pump cycle, pin 31 rests on distal ledge 32a preventing axial translation of piston 27.



FIG. 11 shows cannula valve open state (4). Rotation of piston 27 causes cam surface 33 to engage actuator 28′, releasing compression on O-ring seal 34′ and opening fluid communication between pump volume 47 and cannula port 41 through second aperture 43. FIG. 11A and FIG. 11B show pin 31 resting on distal ledge 32a during this portion of the pump cycle, preventing axial translation of piston 27.


During the pump discharge stroke (5), depicted in FIG. 12, FIG. 12A, and FIG. 12B, eccentric cam surface 33 holds open fluid communication with the cannula port 41 while reservoir port 42 remains closed. FIG. 12A shows piston 27 moved axially in a distal direction as indicated by the arrow. Pin 31 engages the angled axial translation portion of cam surface 32, as shown in FIG. 12B, causing piston 27 to translate away from motor 24 and causing fluid to be discharged from pump volume space 47 through cannula port 41 as indicated by the arrow.


After the piston has completed 360 degrees of rotation, as depicted in FIG. 13, travel sensor 38 is engaged, indicating that the pump cycle is complete. With the pump returned to the cannula valve closed state (6), reservoir port 42 and cannula port 41 are blocked and pin 31 rests on proximal ledge 32b. In the embodiment shown, travel sensor 38 is an ON/OFF switch that detects that the pump has completed a full cycle. However, other sensor systems, such as an encoder wheel and optical sensor, may be used to recognize intermediate states and communicate that information to microprocessor 30. The use of a higher resolution sensor permits the discharge stroke to be incremented. In the embodiment described herein, the discharge stroke includes a complete rotation of piston 27, emptying the contents of pump volume 47, however, a finer resolution of infusion dosage could be implemented without departing from the scope of the invention.


The foregoing description of the preferred embodiments is not to be deemed limiting of the invention, which is defined by the appended claims. The person of ordinary skill in the art, relying on the foregoing disclosure, may practice variants of the embodiments described without departing from the scope of the invention claimed. For example, although described in connection with continuous delivery of insulin for treatment of diabetes, it will be apparent to those of skill in the art that the infusion pump could be adapted to deliver other medications. A feature or dependent claim limitation described in connection with one embodiment or independent claim may be adapted for use with another embodiment or independent claim, without departing from the scope of the invention.

Claims
  • 1. A micropump for delivery of medication by infusion, comprising: a pump housing;a piston positioned in the pump housing having a longitudinal piston axis; anda motor adapted to rotate the piston about the piston axis;the pump housing having an axial opening receiving the piston, a first aperture positioned radially with respect to the piston axis and communicating with a reservoir, and a second aperture radially positioned with respect to the piston axis communicating with a cannula;the piston having an eccentric cam surface at one end thereof, said cam surface adapted to sequentially open and close the first aperture and the second aperture at respective rotational positions of the piston; whereinthe axial position of the piston inside the pump housing determines a pump volume space;wherein the first aperture and the second aperture each contain an O-ring seal and a spring loaded valve actuator, each valve actuator having a tip, the tips of both actuators being in clearance with the eccentric cam in a normally closed position, and a spring force on the seals being high enough to ensure that the valve actuators do not open under operating pressures of the micropump, wherein the eccentric cam sequentially biases each actuator upon rotation of the piston, releasing compression on the respective O-ring seals and permitting fluid flow through the first aperture and the second aperture, respectively.
  • 2. The micropump according to claim 1, wherein the pump housing is stationary, and further comprising an axial position cam surface on the piston, between the motor and the eccentric cam surface, engaging a stationary member on the pump housing, and adapted to translate the piston axially within the pump housing when the piston rotates.
  • 3. The micropump according to claim 2, wherein the stationary member on the pump housing is a cam pin received in an opening in the pump housing.
  • 4. The micropump according to claim 1, wherein the piston is free to rotate but has a fixed axial position and wherein the pump housing is free to translate axially but has a fixed rotational position.
  • 5. The micropump according to claim 1, further comprising a connecter between the motor and the piston, the connector transmitting torque between the motor and the piston, and engaging the piston to permit axial movement of the piston with respect to the connector and prohibit rotational movement of the piston with respect to the connector.
  • 6. The micropump according to claim 5, wherein an axially elongated slot on the pump piston engages a tab on the connector to permit axial movement of the piston with respect to the connector and prohibit rotational movement of the piston with respect to the connector.
  • 7. The micropump according to claim 1, further comprising a microprocessor, and a travel sensor having a contact switch communicating with the microprocessor triggered by rotation of the piston through a complete cycle.
  • 8. The micropump according to claim 1, wherein the reservoir has at least one flexible wall.
  • 9. The micropump according to claim 1, further comprising a microprocessor, a cannula deployment mechanism, a volume sensor in operative communication with the reservoir, a travel sensor in operative communication with the pump piston, and an error condition sensor in operative communication with a fluid line between the second aperture in the pump housing and the cannula, and wherein the motor, the cannula deployment mechanism, the volume sensor, the travel sensor and the error condition sensor are all in operative communication with the microprocessor.
  • 10. A method for delivering medication to a patient by infusion with the pump according to claim 9, comprising the steps of providing instructions to the microprocessor to deploy the cannula, causing the piston to rotate, withdrawing a volume of medication into the pump volume space from the reservoir and expelling the volume of medication through the cannula for infusion of an infusion dosage to a patient.
  • 11. The method according to claim 10, wherein the medication is insulin and the infusion dosage comprises an infusion over one to five days.
  • 12. The method according to claim 11, further comprising the step of disposing of the pump after delivery of the infusion dosage.
  • 13. The method according to claim 10, wherein the infusion dosage comprises a basal segment and at least one bolus segment.
  • 14. The method according to claim 10, wherein the pump volume space is in a range of 1 μl to 10 μl and an infusion dosage is delivered by an integer number of rotations of the piston through 360 degrees.
  • 15. The method according to claim 10, wherein the instructions provided to the microprocessor are programmed with user operable controls located on a wearable pump housing.
US Referenced Citations (254)
Number Name Date Kind
2821926 Miller Feb 1958 A
3510235 Bensinger May 1970 A
3857382 Williams, Jr. et al. Dec 1974 A
3963380 Thomas, Jr. et al. Jun 1976 A
4204538 Cannon May 1980 A
4417860 Justice Nov 1983 A
4465478 Sabelman Aug 1984 A
4479759 Zeitz Oct 1984 A
4685902 Edwards et al. Aug 1987 A
4723947 Konopka Feb 1988 A
4734092 Millerd Mar 1988 A
4755173 Konopka et al. Jul 1988 A
5002528 Palestrant Mar 1991 A
5176662 Bartholomew et al. Jan 1993 A
5226899 Lee et al. Jul 1993 A
5257980 Van Antwerp et al. Nov 1993 A
5279585 Balkwill Jan 1994 A
5279586 Balkwill Jan 1994 A
5312233 Tanny May 1994 A
5453099 Lee et al. Sep 1995 A
5494420 Mawhirt Feb 1996 A
5522803 Teissen-Simony Jun 1996 A
5536249 Castellano et al. Jul 1996 A
5545143 Fischell Aug 1996 A
5545152 Funderburk et al. Aug 1996 A
5549575 Giambattista Aug 1996 A
5569214 Chanoch Oct 1996 A
5582598 Chanoch Dec 1996 A
5593390 Castellano et al. Jan 1997 A
5674204 Chanoch Oct 1997 A
5728074 Castellano et al. Mar 1998 A
5820602 Kovelman et al. Oct 1998 A
5851197 Marano et al. Dec 1998 A
5858001 Tsals et al. Jan 1999 A
5858005 Kriesel Jan 1999 A
5921966 Bendek Jul 1999 A
5925021 Castellano et al. Jul 1999 A
5944700 Nguyen Aug 1999 A
5957895 Sage et al. Sep 1999 A
5957896 Bendek Sep 1999 A
5968011 Larsen et al. Oct 1999 A
5980506 Mathiasen Nov 1999 A
6017328 Fischell et al. Jan 2000 A
6056718 Funderburk et al. May 2000 A
6068615 Brown et al. May 2000 A
6074369 Sage et al. Jun 2000 A
6086575 Mejslov Jul 2000 A
6093172 Funderburk et al. Jul 2000 A
6096010 Walters Aug 2000 A
6110148 Brown et al. Aug 2000 A
6110149 Klitgaard Aug 2000 A
6123690 Mejslov Sep 2000 A
6132400 Waldenburg Oct 2000 A
6175752 Say et al. Jan 2001 B1
6221053 Walters Apr 2001 B1
6248095 Giambattista Jun 2001 B1
6254586 Mann et al. Jul 2001 B1
6272364 Kurnik Aug 2001 B1
6275717 Gross et al. Aug 2001 B1
6277099 Strowe Aug 2001 B1
6277627 Hellinga Aug 2001 B1
6293925 Safabash et al. Sep 2001 B1
6302866 Marggi Oct 2001 B1
6352523 Brown et al. Mar 2002 B1
6355021 Nielsen et al. Mar 2002 B1
6391005 Lum et al. May 2002 B1
6485461 Mason et al. Nov 2002 B1
6520938 Funderburk et al. Feb 2003 B1
6521446 Hellinga Feb 2003 B2
6537242 Palmer Mar 2003 B1
6544212 Galley et al. Apr 2003 B2
6546269 Kurnik Apr 2003 B1
6551276 Mann et al. Apr 2003 B1
6558351 Steil et al. May 2003 B1
6565509 Say et al. May 2003 B1
6576430 Hsieh et al. Jun 2003 B1
6579267 Lynch et al. Jun 2003 B2
6582404 Kitgaard Jun 2003 B1
6589229 Connelly et al. Jul 2003 B1
6607509 Bobroff et al. Aug 2003 B2
6656158 Mahoney et al. Dec 2003 B2
6656159 Flaherty Dec 2003 B2
6669669 Flaherty et al. Dec 2003 B2
6692457 Flaherty Feb 2004 B2
6692472 Hansen Feb 2004 B2
6699218 Flaherty et al. Mar 2004 B2
6706159 Moerman et al. Mar 2004 B2
6723072 Flaherty et al. Apr 2004 B2
6740059 Flaherty May 2004 B2
6749560 Konstrorum et al. Jun 2004 B1
6749587 Flaherty Jun 2004 B2
6768425 Flaherty et al. Jul 2004 B2
6830558 Flaherty et al. Dec 2004 B2
6830562 Mogensen et al. Dec 2004 B2
6840922 Nielsen et al. Jan 2005 B2
6852104 Blomquist Feb 2005 B2
6932794 Giambattista Aug 2005 B2
6936032 Bush, Jr. Aug 2005 B1
6945961 Miller Sep 2005 B2
6949084 Marggi et al. Sep 2005 B2
6960162 Saadat et al. Nov 2005 B2
6960192 Flaherty et al. Nov 2005 B1
6977180 Hellinga et al. Dec 2005 B2
6997907 Safabash et al. Feb 2006 B2
7004928 Aceti et al. Feb 2006 B2
7018360 Flaherty et al. Mar 2006 B2
7018364 Giambattista Mar 2006 B2
7029455 Flaherty Apr 2006 B2
7052251 Nason et al. May 2006 B2
7064103 Pitner et al. Jun 2006 B2
7070580 Nielsen Jul 2006 B2
7083597 Lynch et al. Aug 2006 B2
7104972 Moller Sep 2006 B2
7109878 Mann et al. Sep 2006 B2
7128727 Flaherty et al. Oct 2006 B2
7137964 Flaherty Nov 2006 B2
7144384 Gorman et al. Dec 2006 B2
7169132 Bendek Jan 2007 B2
7207974 Safabash et al. Apr 2007 B2
7214207 Lynch et al. May 2007 B2
7220248 Mernoe May 2007 B2
7226278 Nason et al. Jun 2007 B2
7250037 Shermer et al. Jul 2007 B2
7303543 Maule et al. Dec 2007 B1
7303549 Flaherty et al. Dec 2007 B2
7310544 Brister et al. Dec 2007 B2
7318816 Bobroff et al. Jan 2008 B2
7329239 Safabash et al. Feb 2008 B2
7354420 Steil et al. Apr 2008 B2
7496392 Alarcon et al. Feb 2009 B2
7678079 Shermer et al. Mar 2010 B2
7722595 Pettis et al. May 2010 B2
7726955 Ryser et al. Jun 2010 B2
7857131 Vedrine Dec 2010 B2
8021334 Shekalim Sep 2011 B2
8282366 Hilber Oct 2012 B2
20020040208 Flaherty et al. Apr 2002 A1
20030055380 Flaherty Mar 2003 A1
20030109829 Mogensen et al. Jun 2003 A1
20030176852 Lynch et al. Sep 2003 A1
20030199823 Bobroff et al. Oct 2003 A1
20040002682 Kovelman et al. Jan 2004 A1
20040010207 Flaherty et al. Jan 2004 A1
20040059316 Smedegaard Mar 2004 A1
20040078028 Flaherty et al. Apr 2004 A1
20040092865 Flaherty et al. May 2004 A1
20040092878 Flaherty May 2004 A1
20040116866 Gorman et al. Jun 2004 A1
20040127844 Flaherty Jul 2004 A1
20040153032 Garribotto et al. Aug 2004 A1
20040162521 Bengtsson Aug 2004 A1
20040204673 Flaherty Oct 2004 A1
20040204687 Mogensen et al. Oct 2004 A1
20040220551 Flaherty et al. Nov 2004 A1
20040235446 Flaherty et al. Nov 2004 A1
20040260233 Garibotto et al. Dec 2004 A1
20050021005 Flaherty et al. Jan 2005 A1
20050022274 Campbell et al. Jan 2005 A1
20050043687 Mogensen et al. Feb 2005 A1
20050065760 Murtfeldt et al. Mar 2005 A1
20050090784 Nielsen et al. Apr 2005 A1
20050101932 Cote et al. May 2005 A1
20050101933 Marrs et al. May 2005 A1
20050113761 Faust et al. May 2005 A1
20050124936 Mogensen et al. Jun 2005 A1
20050171512 Flaherty Aug 2005 A1
20050182366 Vogt et al. Aug 2005 A1
20050197625 Haueter Sep 2005 A1
20050203461 Flaherty Sep 2005 A1
20050215982 Malave et al. Sep 2005 A1
20050222645 Malave et al. Oct 2005 A1
20050238507 Dilanni et al. Oct 2005 A1
20050245799 Brauker et al. Nov 2005 A1
20050273076 Beasley et al. Dec 2005 A1
20050276705 Pinkerton Dec 2005 A1
20050283144 Shiono et al. Dec 2005 A1
20060041229 Garibotto et al. Feb 2006 A1
20060074381 Malave et al. Apr 2006 A1
20060122577 Poulsen et al. Jun 2006 A1
20060129090 Moberg et al. Jun 2006 A1
20060135913 Ethelfeld Jun 2006 A1
20060142698 Ethelfeld Jun 2006 A1
20060178633 Garibotto et al. Aug 2006 A1
20060200073 Radmer et al. Sep 2006 A1
20060263839 Ward et al. Nov 2006 A1
20060264835 Nielsen et al. Nov 2006 A1
20060282290 Flaherty et al. Dec 2006 A1
20070016149 Hunn et al. Jan 2007 A1
20070021733 Hansen et al. Jan 2007 A1
20070049865 Radmer et al. Mar 2007 A1
20070060894 Dai Mar 2007 A1
20070073229 Gorman et al. Mar 2007 A1
20070073559 Stangel Mar 2007 A1
20070088244 Miller et al. Apr 2007 A1
20070088271 Richards Apr 2007 A1
20070118405 Campbell et al. May 2007 A1
20070191702 Yodfat et al. Aug 2007 A1
20080004515 Jennewine Jan 2008 A1
20080051697 Mounce et al. Feb 2008 A1
20080051698 Mounce et al. Feb 2008 A1
20080051709 Mounce et al. Feb 2008 A1
20080051710 Moberg et al. Feb 2008 A1
20080051711 Mounce et al. Feb 2008 A1
20080051714 Moberg et al. Feb 2008 A1
20080051716 Stutz Feb 2008 A1
20080051718 Kavazov et al. Feb 2008 A1
20080051727 Moberg et al. Feb 2008 A1
20080051730 Bikovsky Feb 2008 A1
20080051738 Griffin Feb 2008 A1
20080051765 Mounce Feb 2008 A1
20080086111 Cowan Apr 2008 A1
20080097321 Mounce et al. Apr 2008 A1
20080097326 Moberg et al. Apr 2008 A1
20080097327 Bente et al. Apr 2008 A1
20080097328 Moberg et al. Apr 2008 A1
20080097375 Bikovsky Apr 2008 A1
20080097381 Moberg et al. Apr 2008 A1
20080114305 Gerondale May 2008 A1
20080116647 Anderson et al. May 2008 A1
20080119707 Stafford May 2008 A1
20080132842 Flaherty Jun 2008 A1
20080147041 Kristensen Jun 2008 A1
20080160492 Campbell et al. Jul 2008 A1
20080187449 Breidenbach Aug 2008 A1
20080194924 Valk et al. Aug 2008 A1
20080215006 Thorkild Sep 2008 A1
20080261255 Tolosa et al. Oct 2008 A1
20080264261 Kavazov et al. Oct 2008 A1
20080269680 Ibranyan et al. Oct 2008 A1
20080269713 Kavazov Oct 2008 A1
20080294028 Brown Nov 2008 A1
20080306434 Dobbles et al. Dec 2008 A1
20080312608 Christoffersen et al. Dec 2008 A1
20090005724 Regittnig et al. Jan 2009 A1
20090005728 Weinert et al. Jan 2009 A1
20090012472 Ahm et al. Jan 2009 A1
20090048563 Ethelfeld et al. Feb 2009 A1
20090062767 Van Antwerp et al. Mar 2009 A1
20090062778 Bengtsson et al. Mar 2009 A1
20090076453 Mejlhede et al. Mar 2009 A1
20090112155 Zhao Apr 2009 A1
20090149743 Barron Jun 2009 A1
20090204077 Hasted et al. Aug 2009 A1
20090221971 Mejlhede et al. Sep 2009 A1
20090254037 Bryant, Jr. Oct 2009 A1
20090326472 Carter Dec 2009 A1
20100049127 Haueter Feb 2010 A1
20110021990 Navarro Jan 2011 A1
20110021993 Bar-Haim Jan 2011 A1
20110054400 Chong et al. Mar 2011 A1
20110230838 Adams Sep 2011 A1
20130017099 Genoud Jan 2013 A1
20130060194 Rotstein Mar 2013 A1
20140170003 Bergman et al. Jun 2014 A1
Foreign Referenced Citations (21)
Number Date Country
0980687 Feb 2000 EP
1044374 Oct 2008 EP
2019206 Jan 2009 EP
2187104 May 2010 EP
2003509133 Mar 2003 JP
2004503303 Feb 2004 JP
2004524869 Aug 2004 JP
2005520646 Jul 2005 JP
2006526467 Nov 2006 JP
9320864 Oct 1993 WO
WO 9934212 Jul 1999 WO
WO 03074121 Sep 2003 WO
WO 2004032994 Apr 2004 WO
2005039674 May 2005 WO
WO 2007051139 May 2007 WO
WO 2008040812 Apr 2008 WO
WO 2009004627 Jan 2009 WO
WO 2009021039 Feb 2009 WO
WO 2009021052 Feb 2009 WO
WO 2012069308 May 2012 WO
WO 2012126744 Sep 2012 WO
Related Publications (1)
Number Date Country
20160000999 A1 Jan 2016 US